Research Article

Should we have any predictive marker for estimating the severity of community-acquired pneumonia at admission?

Volume: 3 Number: 3 September 26, 2022
EN TR

Should we have any predictive marker for estimating the severity of community-acquired pneumonia at admission?

Abstract

Aim: Community-acquired pneumonia (CAP) is a disease that affects children. One hundred fifty-five million children under five years are diagnosed with pneumonia yearly, 20 million are hospitalized, and 2 million die. Early diagnosis and severity assessment reduce mortality and morbidity. This study aimed to determine the effect of basic hemogram parameters, neutrophil-lymphocyte ratio (NLR), immature (IG) granulocyte, immature granulocyte percentage (IG%), C-reactive protein (CRP), and oxygen saturation. Material and Method: This case-control study was conducted between November 2018 and May 2019 at Erciyes University School of Medicine in the Department of Paediatric Pulmonology. Sixty-nine patients diagnosed with CAP had enrolled in the study by clinical and radiological findings. The patients were classified into two subgroups: mild-to-moderate pneumonia and severe pneumonia. The CAP severity of the disease was determined using the criteria indicated for children by the British Thoracic Society. Univariate analysis was used to identify independent factors that affect the severity of pneumonia. Results: Pneumonia was mild-moderate in 46.3% (n=32/69) patients. Pneumonia was severe in 63% (n=37/69) of patients. Leukocytes, neutrophils, IGn, IG%, and saturations of these two groups were compared. There was a statistically significant difference between the two groups (p 0.05). However, there was no statistically significant difference in lymphocyte count, NLR, or CRP (p>0.05). Leukocytes, neutrophils, IGn, IG%, and saturation significantly predicted pneumonia severity (p<0.05). Conclusion: Our studies show that increased IGn, IG%, and decreased oxygen saturation are related to severe outcomes in children with pneumonia. They may be effective parameters in determining the severity of pneumonia.

Keywords

Supporting Institution

herhangi bir destekleyen kurum yok

References

  1. Harris M, Clark J, Coote N, et al. British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for managing community-acquired pneumonia in children: update 2011. Thorax 2011; 66: 1-23.
  2. Wardlaw T, Salama P, Johansson EW, Mason E. Pneumonia: the leading killer of children. Lancet 2006; 368: 1048-50.
  3. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008; 86: 408-16.
  4. Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008; 121: 219-25.
  5. Krüger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008; 31: 349-35.
  6. Hangul M, Ozturk D, Keti DB, Demirkan FG, Kose M. Plasma kallistatin levels in children with community-acquired pneumonia. Pediatr Allergy Immunol Pulmonol 2018; 31: 146-50.
  7. Florin TA, Ambroggio L, Brokamp C, et al. Proadrenomedullin predicts severe disease in children with suspected community-acquired pneumonia. Clin Infect Dis 2021; 73: 524-30
  8. Esposito S, Di Gangi M, Cardinale F, et al. Sensitivity and Specificity of soluble triggering receptor expressed on myeloid cells-1, midregional proatrial natriuretic peptide and midregional proadrenomedullin for distinguishing etiology and to assess severity in community-acquired pneumonia. PLoS One 2016; 1: 0163262.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

September 26, 2022

Submission Date

August 8, 2022

Acceptance Date

September 11, 2022

Published in Issue

Year 2022 Volume: 3 Number: 3

APA
Hangül, M., Köse, M., Pür, H., Doğan, M., Türk, E., Ersoy, A., & Öztürk, M. A. (2022). Should we have any predictive marker for estimating the severity of community-acquired pneumonia at admission? Journal of Medicine and Palliative Care, 3(3), 221-227. https://doi.org/10.47582/jompac.1159549
AMA
1.Hangül M, Köse M, Pür H, et al. Should we have any predictive marker for estimating the severity of community-acquired pneumonia at admission? J Med Palliat Care / JOMPAC / jompac. 2022;3(3):221-227. doi:10.47582/jompac.1159549
Chicago
Hangül, Melih, Mehmet Köse, Hüseyin Pür, et al. 2022. “Should We Have Any Predictive Marker for Estimating the Severity of Community-Acquired Pneumonia at Admission?”. Journal of Medicine and Palliative Care 3 (3): 221-27. https://doi.org/10.47582/jompac.1159549.
EndNote
Hangül M, Köse M, Pür H, Doğan M, Türk E, Ersoy A, Öztürk MA (September 1, 2022) Should we have any predictive marker for estimating the severity of community-acquired pneumonia at admission? Journal of Medicine and Palliative Care 3 3 221–227.
IEEE
[1]M. Hangül et al., “Should we have any predictive marker for estimating the severity of community-acquired pneumonia at admission?”, J Med Palliat Care / JOMPAC / jompac, vol. 3, no. 3, pp. 221–227, Sept. 2022, doi: 10.47582/jompac.1159549.
ISNAD
Hangül, Melih - Köse, Mehmet - Pür, Hüseyin - Doğan, Murat - Türk, Emrah - Ersoy, Ali - Öztürk, Mehmet Adnan. “Should We Have Any Predictive Marker for Estimating the Severity of Community-Acquired Pneumonia at Admission?”. Journal of Medicine and Palliative Care 3/3 (September 1, 2022): 221-227. https://doi.org/10.47582/jompac.1159549.
JAMA
1.Hangül M, Köse M, Pür H, Doğan M, Türk E, Ersoy A, Öztürk MA. Should we have any predictive marker for estimating the severity of community-acquired pneumonia at admission? J Med Palliat Care / JOMPAC / jompac. 2022;3:221–227.
MLA
Hangül, Melih, et al. “Should We Have Any Predictive Marker for Estimating the Severity of Community-Acquired Pneumonia at Admission?”. Journal of Medicine and Palliative Care, vol. 3, no. 3, Sept. 2022, pp. 221-7, doi:10.47582/jompac.1159549.
Vancouver
1.Melih Hangül, Mehmet Köse, Hüseyin Pür, Murat Doğan, Emrah Türk, Ali Ersoy, Mehmet Adnan Öztürk. Should we have any predictive marker for estimating the severity of community-acquired pneumonia at admission? J Med Palliat Care / JOMPAC / jompac. 2022 Sep. 1;3(3):221-7. doi:10.47582/jompac.1159549

TR DİZİN ULAKBİM and International Indexes (1d)

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
 


 

download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiVHJfSW5kZXhfbG9nby5wbmciLCJwYXRoIjoiN2EzMC84NTVhL2UyMWMvNjlkZjRkZmVhNTUyNTYuNzg3NjU2ODgucG5nIiwiZXhwIjoxNzc2MjQ1Nzc0LCJub25jZSI6IjU0MDZkMWE2NmE1Y2QwZTJjNGYyNDA1OTM2MTE0YWIxIn0.Tt-WScFXTj5r2jji5eDMFApNzujLMjMPl8ivXRbozSI



f9ab67f.png
asos-index.png


 


download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiQ3Jvc3NyZWYuanBnIiwicGF0aCI6IjAzMzEvMTdkZi8yN2ZkLzY5ZGY0ZThhMDZkMjg0LjQxMjAyNDg5LmpwZyIsImV4cCI6MTc3NjI0NTkxNCwibm9uY2UiOiI2NjM1Yjc5MWFiY2I1MDQ0NjkzMTAxMDhjY2Y2NzRlMCJ9.5jDQBEY-KErkDK1QjDmv9ichOkNIn5CWYibe1Wz1644
icmje_1_orig.png
 
cc.logo.large.png
 
ncbi.png
 
google-scholar.pngpn6krf5.jpg
 


 

Our journal is in TR-Dizin, DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index, Eurasian Scientific Journal Index (ESJI), and Turkiye Citation Index.

EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation. 

 

Journal articles are evaluated as "Double-Blind Peer Review"